MOSCOW, Feb 2 — German company BioNTech plans to produce two billion doses of coronavirus vaccine in 2021 due to increased global demand, reported Sputnik news agency.
“In order to respond to an increased global demand, we plan to manufacture two billion doses of our Covid-19 vaccine in 2021 by expanding the previously expected output of 1.3 billion doses by more than 50 per cent,” BioNTech said in a statement.
“We are on track to scale-up our manufacturing capacities,” the statement said.
— Bernama
The post BioNTech plans to manufacture 2 bln doses of Covid-19 vaccine in 2021 appeared first on Selangor Journal.
